Biotech

All Articles

Amgen documents 1st period 3 win for $400M dermatitis drug

.Amgen has actually discussed (PDF) the initial period 3 data on its own $400 million eczema medicat...

Biogen, UCB report period 3 lupus succeed after neglecting earlier test

.Biogen and UCB's bank on developing in to period 3 on the back of a broken study seeks to have actu...

Aptadir wishes brand-new RNA inhibitors can turn around challenging cancers cells

.Italian biotech Aptadir Rehabs has introduced along with the pledge that its own pipe of preclinica...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has satisfied its own objective in a Duchenne muscle dystrophy (DMD) research st...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, ...

Achilles drops tissue treatment system, bandages for unemployments after skipping 'business stability' objectives

.Achilles Therapies has actually torn up its technique. The British biotech is knocking off on its o...

Aligos heralds stage 2 MASH gain, lowering liver excess fat up to 46%

.Aligos Therapies is advertising a midstage succeed in metabolic-dysfunction linked steatohepatitis ...

Basilea scores $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job developing brand new antifungals has acquired a significant increase fr...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Having actually gathered up the united state liberties to Capricor Therapeutics' late-stage Duchenn...

FDA fragments adcomm for Applied's rare disease drug

.After dismissing the choice meeting for Applied Therapeutics' metabolic disorder medicine govoresta...